WebDoctor Encyclopedia

Genitourinary

Spermatocytic tumour of the testis

A spermatocytic tumour is a rare testicular germ cell tumour, formerly called spermatocytic seminoma, that mainly affects older men. It usually causes a painless swelling, has normal tumour markers and is almost always cured by removing the testicle.

Medically reviewed Last reviewed October 20, 2026

What is a spermatocytic tumour of the testis?

A spermatocytic tumour is a rare testicular tumour that develops from germ cells, the cells that normally go on to form sperm. It used to be called spermatocytic seminoma, but that name was dropped because the tumour is not a type of seminoma. It differs from ordinary seminoma in almost every way: the age of the men it affects, its appearance under the microscope, its genetics and its behaviour (Eble, 1994).

Spermatocytic tumours make up only about 1 in 100 testicular cancers (Secondino et al., 2023). Unlike most testicular cancers, which peak in young men, they usually affect older men, typically in their 50s or older. In a classic review, the youngest patient was 25 and the oldest 87, with an average age of 54 (Eble, 1994).

Most spermatocytic tumours are found as a painless swelling of one testicle. They grow slowly and almost never spread, so removing the testicle (orchidectomy) is usually the only treatment needed.

A small minority of these tumours, however, contain a sarcoma or have anaplastic (very abnormal) cells. These rare variants can spread quickly and respond poorly to chemotherapy, so the pathologist’s report is very important.

1. Key facts at a glance

Feature Details
Type of tumour Germ cell tumour not derived from germ cell neoplasia in situ
Former name Spermatocytic seminoma
How common About 1% of testicular cancers
Typical age Mostly over 50; range from the 20s to the 80s
Main symptom Painless, often large, swelling of one testicle
Tumour markers (AFP, hCG) Normal
Main treatment Removal of the testicle (radical orchidectomy)
Spread Very rare for the usual type; common with sarcomatous or anaplastic variants
Outlook Excellent for the usual type

2. Types of spermatocytic tumour

Type Description Behaviour
Classic spermatocytic tumour Three sizes of cells: small, medium and large Almost always benign in behaviour
Anaplastic spermatocytic tumour Sheets of uniform, very abnormal medium-sized cells Can be more aggressive
Spermatocytic tumour with sarcoma Contains an added sarcoma, for example rhabdomyosarcoma or undifferentiated spindle cell sarcoma Often spreads; poor outlook

In a review of 146 published patients, metastatic disease was found in about two in five patients with sarcomatous or anaplastic tumours, compared with one in twenty of those with the usual type (Grogg et al., 2019).

How it differs from seminoma

Feature Spermatocytic tumour Classic seminoma
Typical age Over 50 25-45
Origin Not from germ cell neoplasia in situ From germ cell neoplasia in situ
Undescended testis link Not linked; occurs in descended testes Linked
Appearance Soft, gelatinous Firm, cream-coloured
Cells Three cell sizes One cell type
Markers and stains Negative for OCT3/4 and PLAP Positive for OCT3/4 and PLAP
Spread Very rare Can spread to lymph nodes
Treatment after surgery Usually none Surveillance, radiotherapy or chemotherapy

3. Causes and risk factors

The cause is not fully understood. Research suggests that the tumour begins in mature germ cells later in life, rather than in fetal cells as most testicular cancers do.

Factor Notes
Older age The main risk factor
Gene changes Gains of chromosome 9, including the DMRT1 gene; mutations in FGFR3 or HRAS in some tumours
Undescended testis Not a recognised risk factor, unlike other testicular cancers
Family history No clear inherited pattern

The FGFR3 and HRAS mutations are the same type that increase in sperm cells with age. This may explain why the tumour mainly affects older men.

4. How does it look

On self-examination

Feature Description
Size Often large; more than half are over 5 cm
Feel Smooth, soft or rubbery swelling
Pain Usually none
Sides Usually one testicle; occasionally both

On ultrasound

The tumour appears as a well-defined solid mass inside the testicle, sometimes with cystic or fluid-like areas.

Under the microscope

Feature Description
Cut surface Soft, pale and gelatinous or watery (oedematous)
Cells Three populations: small lymphocyte-like cells, medium cells and large cells
Nuclei Round, with characteristic thread-like (“spireme”) chromatin in larger cells
Background Few inflammatory cells, unlike seminoma
Stains Positive for SALL4 and DMRT1; negative for OCT3/4
Surrounding tubules No germ cell neoplasia in situ

Recognising the three-cell pattern helps avoid confusion with seminoma or lymphoma (Rabade et al., 2022).

5. Symptoms

Common symptoms

  • A painless lump or swelling in one testicle
  • A feeling of heaviness in the scrotum
  • Gradual increase in size over months or years

Less common symptoms

Symptom What it may mean
Aching in the scrotum or groin Large tumour
Back pain Rarely, spread to lymph nodes at the back of the abdomen
Breathlessness or cough Rarely, spread to the lungs, usually with sarcomatous variants
Rapid enlargement May suggest a sarcomatous component

When to seek medical advice

See a doctor if you notice any new lump, swelling or change in a testicle, at any age. Testicular lumps in older men are sometimes put down to fluid or infection, but a scrotal ultrasound can quickly show whether a solid tumour is present.

6. Diagnosis

Test Purpose
Examination of the testicles Assesses the lump
Scrotal ultrasound Confirms a solid tumour inside the testicle
Tumour markers (AFP, hCG, LDH) Usually normal; help exclude other germ cell tumours
Radical orchidectomy Removes the testicle through a groin incision for diagnosis and treatment
Pathology with special stains Confirms the diagnosis and looks for anaplastic or sarcomatous areas
CT of the chest, abdomen and pelvis Checks for spread, especially with aggressive variants

Why the pathology report matters

Because a spermatocytic tumour can be confused with other testicular tumours, the specimen is often reviewed by a specialist uropathologist. The report confirms the three-cell pattern, checks the stains, and looks carefully through the whole tumour for any sarcoma or anaplastic areas. It also records the tumour size and whether the tumour has reached the blood vessels, the spermatic cord or the outer covering of the testicle.

These details decide whether routine surveillance is enough or whether closer scans and further treatment should be discussed.

Staging

Spermatocytic tumours are staged with the same TNM and stage system as other testicular tumours. Most are stage I, confined to the testicle, at diagnosis (Secondino et al., 2023).

Other causes of a testicular lump in older men

Condition Typical features
Hydrocele Fluid around the testicle; soft swelling that lets light through
Epididymal cyst Small, separate lump above or behind the testicle
Epididymo-orchitis Painful, red, swollen testicle, often with fever or urinary symptoms
Testicular lymphoma The most common testicular cancer in men over 60; may affect both sides
Classic seminoma Less common at this age, but possible
Hernia Swelling that extends from the groin and may come and go

An ultrasound scan is the quickest way to tell these conditions apart.

7. Treatment

Surgery

Radical orchidectomy is the standard treatment. The testicle is removed through a cut in the groin, together with the spermatic cord. Almost all patients in published series were treated this way (Grogg et al., 2019). A prosthetic testicle can be inserted at the same time if wanted.

Question Current view
Testis-sparing surgery? Not supported by current evidence
Radiotherapy after surgery? Not needed for the usual type
Chemotherapy after surgery? Not needed for the usual type
Lymph node surgery? Considered only for selected aggressive or metastatic cases

Aggressive variants and spread

For tumours with a sarcoma or anaplastic pattern, or when the cancer has spread, treatment is individual. Options include:

Treatment Notes
Retroperitoneal lymph node dissection Removes affected lymph nodes at the back of the abdomen
Chemotherapy Germ cell regimens such as BEP, or sarcoma regimens when a sarcoma is present
Radiotherapy For selected sites
Clinical trials Encouraged because evidence is limited

Metastatic spermatocytic tumours respond less well to chemotherapy than ordinary testicular germ cell cancers (Grogg et al., 2019).

Side effects of orchidectomy

Effect Notes
Pain and bruising Usually settles within a couple of weeks
Change in appearance Can be addressed with a prosthesis
Hormone levels Usually normal if the other testicle is healthy
Fertility Usually preserved with one healthy testicle; sperm banking can be discussed

Recovery after orchidectomy

Time after surgery What is typical
Day of surgery Usually a day-case procedure or a single night in hospital
First week Groin and scrotal discomfort; supportive underwear helps
Weeks 2-4 Return to most normal activities and desk work
Weeks 4-6 Heavy lifting and strenuous exercise can usually resume
First clinic visit Discussion of the pathology report and follow-up plan

Monthly self-examination

Step How to do it
Choose the right time After a warm bath or shower, when the scrotum is relaxed
Check each side Roll the testicle gently between thumb and fingers
Know what is normal The epididymis is a soft tube at the back; this is normal
Look for changes Lumps, swelling, hardness or a change in size
Act promptly Report anything new to your doctor without delay

8. Outlook (prognosis)

Situation Usual outlook
Classic spermatocytic tumour, stage I Excellent; surgery is usually curative
Anaplastic variant Usually good, but follow-up is closer
Sarcomatous variant Poor; frequent early spread
Metastatic disease Limited survival, from about 1 to 25 months in reported cases (Grogg et al., 2019)

When the usual type spreads, it tends to do so early. In the review by Grogg and colleagues, metastases appeared within about two years, typically within the first six months. Larger tumours were also more likely to spread.

9. Follow-up

Follow-up Purpose
Clinic review and examination Checks the remaining testicle and the abdomen
CT scans More frequent in the first 2 years, especially for large or aggressive tumours
Blood tests Hormones and general health
Self-examination Monthly check of the remaining testicle

10. Living with a spermatocytic tumour

  • Examine your remaining testicle each month and report any change
  • Attend scans in the first few years after surgery, even if you feel completely well
  • Ask about a prosthesis if appearance concerns you
  • Tell your doctor about tiredness, low mood or low sex drive, which could suggest low testosterone
  • Talk to your partner or a counsellor if you feel anxious after surgery
  • Keep a copy of your pathology report, which is useful if you move or see a new specialist
  • Report back pain, cough or breathlessness between appointments
  • Seek support from testicular cancer charities

11. Frequently asked questions

Question Answer
Is it the same as seminoma? No; despite the old name, it is a different tumour
Will I need chemotherapy? Usually not, unless the tumour is an aggressive variant or has spread
Can it affect both testicles? Occasionally
Will I still produce testosterone? Usually yes, from the other testicle
Is it inherited? No
How long will follow-up last? Usually several years, with most scans in the first two
Why are my tumour markers normal? Spermatocytic tumours do not usually produce AFP or hCG
Can I keep part of the testicle? Testis-sparing surgery is not currently recommended
Is it common in young men? No; it mainly affects older men, unlike most testicular cancers
Will it affect my sex life? Usually not, as long as the other testicle works normally

12. Questions to ask your care team

  • Does my tumour have any anaplastic or sarcomatous areas?
  • What stage is it?
  • Do I need any treatment after surgery?
  • How often will I need CT scans?
  • Should I consider a testicular prosthesis?
  • Will my hormone levels be checked?
  • Has my tumour been reviewed by a specialist pathologist?

Resources

  1. Eble, J.N. (1994) ‘Spermatocytic seminoma’, Human Pathology, 25(10), pp. 1035-1042.
  2. Grogg, J.B. et al. (2019) ‘A systematic review of treatment outcomes in localised and metastatic spermatocytic tumors of the testis’, Journal of Cancer Research and Clinical Oncology, 145(12), pp. 3037-3045.
  3. Rabade, K. et al. (2022) ‘Spermatocytic tumor of testis: a case series of 26 cases elucidating unusual patterns with diagnostic and treatment dilemmas’, Journal of Cancer Research and Therapeutics, 18(Supplement), pp. S449-S454.
  4. Secondino, S. et al. (2023) ‘Spermatocytic tumor: a review’, International Journal of Molecular Sciences, 24(11), 9529.
  5. National Cancer Institute (2026) Testicular Cancer Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/testicular/hp/testicular-treatment-pdq (Accessed: October 2026).

Prepared by the editorial team, October 2026.